Edwards Lifesciences (NYSE: EW)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-28 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.570 | 0.600 | 0.0300 | ||||
REV | 1.310B | 1.341B | 31.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Edwards Lifesciences (NYSE: EW) through any online brokerage.
Other companies in Edwards Lifesciences’s space includes: Steris (NYSE:STE), Masimo (NASDAQ:MASI), Envista Holdings (NYSE:NVST), Koninklijke Philips (NYSE:PHG) and Smith & Nephew (NYSE:SNN).
The latest price target for Edwards Lifesciences (NYSE: EW) was reported by Citigroup on Tuesday, May 17, 2022. The analyst firm set a price target for 115.00 expecting EW to rise to within 12 months (a possible 18.08% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Edwards Lifesciences (NYSE: EW) is $97.39 last updated May 17, 2022, 8:00 PM UTC.
There are no upcoming dividends for Edwards Lifesciences.
Edwards Lifesciences’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Edwards Lifesciences.
Edwards Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.